Current Price
Target Price
SomaLogic Inc. (SLGC) is a leading biotechnology firm revolutionizing the field of precision medicine through its proprietary SomaScan® platform, which specializes in protein biomarker discovery and analysis. Leveraging...|
e.g. Promoter holding
Loading chart...
Analyst consensus EPS and Revenue forecasts.
Earnings estimates are not available for this company.
| S.No. | Name | Symbol | Market Cap | P/E | P/B | Profit Margin | Op. Margin | ROE | Rev. Growth |
|---|---|---|---|---|---|---|---|---|---|
| 1. | AAmerican W... | AMWL | $202.17M | — | 0.96 | -27.00% | -24.90% | -22.80% | -13.00% |
| 2. | SSo-Young I... | SY | $203.24M | — | 0.92 | -15.60% | -16.90% | -15.00% | 45.60% |
| 3. | SSomaLogic... | SLGCW | — | — | — | -159.50% | -108.50% | -23.70% | -47.10% |
| 4. | WWeave Comm... | WEAV | $595.33M | — | 7.01 | -7.97% | -6.22% | -25.10% | 15.50% |
| 5. | TTalkspace... | TALKW | — | — | — | -55.40% | -52.80% | -45.70% | 10.60% |
Consolidated Figures in Millions / View Standalone.
| Quarter (M) | Dec 21 | Mar 22 | Jun 22 | Sep 22 | Dec 22 | Mar 23 | Jun 23 | Sep 23 |
|---|---|---|---|---|---|---|---|---|
Revenue | 22.99 | 22.98 | 14.14 | 41.71 | 18.83 | 20.38 | 20.47 | 22.05 |
COGS | 10.46 | 11.65 | 7.08 | 11.67 | 12.96 | 12.32 | 11.18 | 11.63 |
Gross Profit | 12.53 | 11.33 | 7.07 | 30.04 | 5.86 | 8.06 | 9.29 | 10.41 |
Gross Profit % | 54.5% | 49.3% | 49.96% | 72.02% | 31.14% | 39.57% | 45.4% | 47.23% |
| 40.89 | 44.62 | 54.45 | 70.66 | 60.34 | 48.26 | 40.39 | 34.34 | |
EBIT | -28.36 | -33.29 | -47.38 | -40.61 | -54.48 | -40.19 | -31.09 | -28.08 |
OPM % | -123.33% | -144.85% | -334.99% | -97.36% | -289.35% | -197.23% | -151.92% | -127.37% |
Non-Operating Income | 5.05 | 29.31 | 24.4 | 7.05 | 5.13 | 5.99 | 6.33 | 6.4 |
PBT | -23.31 | -3.98 | -22.98 | -33.56 | -49.35 | -34.2 | -24.77 | -21.68 |
Income Tax | 0.27 | -29.31 | -24.4 | -0.62 | -0.1 | 0 | 0 | 0.48 |
Tax Rate % | -1.17% | 736.57% | 106.14% | 1.85% | 0.19% | -0.01% | -0.01% | -2.2% |
Net Income | -23.31 | 25.33 | 1.41 | -32.94 | -49.25 | -34.2 | -24.77 | -22.16 |
NPM % | -101.36% | 110.22% | 9.98% | -78.97% | -261.57% | -167.83% | -121.03% | -100.49% |
Consolidated Figures in Millions / View Standalone.
| Period (M) | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 |
|---|---|---|---|---|---|
Revenue | 32.19 | 55.89 | 81.63 | 97.67 | 81.72 |
COGS | 49.72 | 22.61 | 33.46 | 43.36 | 48.09 |
Gross Profit | -17.53 | 33.27 | 48.16 | 54.3 | 33.63 |
Gross Profit % | -54.47% | 59.54% | 59% | 55.6% | 41.15% |
| 33.99 | 67.63 | 121.47 | 230.06 | 234.26 | |
EBIT | -50.96 | -34.36 | -73.3 | -175.76 | -152.53 |
OPM % | -158.32% | -61.47% | -89.8% | -179.96% | -186.64% |
Non-Operating Income | -6.04 | -18.66 | -14.24 | 65.89 | 22.53 |
PBT | -57 | -53.02 | -87.55 | -109.87 | -130.01 |
Income Tax | 0 | 18.34 | -1.25 | -0.72 | 0 |
Tax Rate % | - | -34.59% | 1.42% | 0.65% | - |
Net Income | -57 | -71.35 | -86.3 | -109.16 | -130.38 |
NPM % | -177.1% | -127.67% | -105.73% | -111.77% | -159.54% |
Consolidated Figures in Millions / View Standalone.
| Period (M) | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 |
|---|---|---|---|---|
| 14.06 | 164.94 | 439.49 | 421.83 | |
| 31.5 | 39.95 | 218.22 | 127.04 | |
| 5.71 | 3.91 | 9.56 | 19.56 | |
| 14.21 | 27.08 | 33.85 | 42.11 | |
| 5.79 | 6.4 | 4.99 | 36.83 | |
Total Assets | 71.26 | 242.29 | 706.1 | 647.37 |
| 0.73 | 0.01 | 0.02 | 0.02 | |
| 19.69 | 185.91 | 612.01 | 562.54 | |
| 0 | 36.67 | 0.07 | 2.48 | |
| 8.9 | 13.61 | 26.2 | 37.47 | |
| 41.94 | 6.09 | 67.81 | 44.87 | |
Total Liabilities | 71.26 | 242.29 | 706.1 | 647.37 |
Consolidated Figures in Millions / View Standalone.
| Period (M) | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 |
|---|---|---|---|---|---|
| -50.54 | -28.34 | -36.97 | -100.67 | -117.25 | |
| 30.66 | -9.54 | -185.43 | 82.54 | 0 | |
| 0.14 | 188.77 | 497.49 | 5.18 | 0.72 | |
Net CFNet Cash Flow | -19.73 | 150.89 | 275.09 | -12.94 | -116.53 |
FCFFree Cash Flow | -51.22 | -29.5 | -43.7 | -105.88 | -121.89 |
Financial ratios and valuation metrics by fiscal year.
| Period | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 |
|---|---|---|---|---|
| - | -69.2% | -21.6% | -18.6% | |
| - | 0.20 | 0.00 | 0.00 | |
| 6.71 | 13.03 | 23.61 | 13.42 | |
| - | 0.36 | 0.17 | 0.14 | |
Cash Conversion | 0.89 | 0.40 | 0.43 | 0.92 |
Payout Ratio | - | - | - | - |
| - | 73.6% | 46.1% | 19.7% | |
| - | - | - | - | |
| - | - | - | - | |
| 3.00 | 5.00 | 4.00 | 3.00 | |
| - | -2.49 | -0.81 | 0.98 | |
| 0.00 | 66.67 | 66.67 | 66.67 | |
| -1.8% | -1.3% | -1.1% | -1.1% |
Note: These ratios and scores are calculated using publicly available financial data and may differ from other sources. Users are advised to verify calculations independently using SEC filings or other official sources before making investment decisions.
Who owns SomaLogic Inc - Class A, from SEC filings
Who owns the company, quarter by quarter
Calendar quarters (13F report dates). Dec 2024 can still change as late 13F amendments arrive.
| Shares held | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | QoQ |
|---|---|---|---|---|---|---|---|---|---|
| 55.7M | 55.7M | 11.6M | 11.6M | 10.9M | 10.9M | 10.8M | 632.5K | -10.1M | |
ForeignForeign institutions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
USUS institutions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Govt.Government & pensions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of institutional holders | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Insiders = officers, directors and 10% owners (Forms 3/4/5). Foreign vs US = the 13F manager's registered address. Government = sovereign funds, central banks and public pensions. Public includes retail investors and funds below the $100M 13F threshold. Named holders are the largest 13F filers each quarter; shares outstanding come from the 10-K / 10-Q cover page.
| Holder | Type | Based in | Shares | % of class | Latest filing |
|---|---|---|---|---|---|
| Investment adviser | DE | 0 | 0.00% | SC 13G/A · 11 Jan 2025 |
Anyone owning more than 5% must file a Schedule 13D (active) or 13G (passive). Structured filings since December 2024; a holder that drops below 5% files an exit amendment. 13F still covers them in the shareholding table.
| Settlement date | Short shares | Change | Days to cover | Relative size |
|---|---|---|---|---|
| 29 Dec 2023 | 5,691,004 | -20.3% | 2.77 | |
| 15 Dec 2023 | 7,142,704 | -5.6% | 3.86 | |
| 30 Nov 2023 | 7,568,205 | -1.5% | 9.43 | |
| 15 Nov 2023 | 7,683,094 | -1.6% | 4.49 | |
| 31 Oct 2023 | 7,805,749 | -1.2% | 5.32 | |
| 13 Oct 2023 | 7,900,268 | -16.5% | 2.64 | |
| 29 Sep 2023 | 9,459,212 | +11.9% | 10.04 | |
| 15 Sep 2023 | 8,453,662 | -16.4% | 10.04 | |
| 31 Aug 2023 | 10,107,623 | -3.6% | 10.07 | |
| 15 Aug 2023 | 10,490,125 | +9.4% | 9.77 | |
| 31 Jul 2023 | 9,588,833 | +4.2% | 11.22 | |
| 14 Jul 2023 | 9,199,053 | +1.9% | 12.57 | |
| 30 Jun 2023 | 9,023,535 | +0.1% | 6.21 | |
| 15 Jun 2023 | 9,010,700 | +1.6% | 7.49 | |
| 31 May 2023 | 8,871,253 | -5.5% | 10.81 | |
| 15 May 2023 | 9,382,999 | -2.2% | 14.17 | |
| 28 Apr 2023 | 9,593,868 | +2.2% | 10.71 | |
| 14 Apr 2023 | 9,385,666 | +5.3% | 6.68 | |
| 31 Mar 2023 | 8,916,271 | +1.4% | 6.37 | |
| 15 Mar 2023 | 8,789,666 | +8.5% | 8.97 | |
| 28 Feb 2023 | 8,101,467 | +2.0% | 9.55 | |
| 15 Feb 2023 | 7,939,305 | -2.9% | 8.62 | |
| 31 Jan 2023 | 8,177,821 | -10.6% | 9.43 | |
| 13 Jan 2023 | 9,147,372 | +12.9% | 6.73 |
FINRA consolidated short interest, reported twice a month for every US listing.
SomaLogic Inc - Class A's SEC filings and earnings call transcripts
What recent news says about SomaLogic Inc - Class A, scored for sentiment.